Nanoparticle Formulation of a Poorly Soluble Kinase Inhibitor: A Technical Note on Scale-Up. Translational Medicine & Therapeutics Journal, [S. l.], v. 1, n. 2, p. 92–100, 2022. DOI: 10.5281/zenodo.22648994. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/74. Acesso em: 5 nov. 2026.